|
Volumn 297, Issue 5589, 2002, Pages 2013-
|
BLM heterozygosity and the risk of colorectal cancer
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
GENE PRODUCT;
PROTEIN BLM;
UNCLASSIFIED DRUG;
CANCER;
ADULT;
AGED;
ALLELISM;
ARTICLE;
BLOOM SYNDROME;
CANCER RISK;
COLORECTAL CARCINOMA;
ETHNIC DIFFERENCE;
GENE EXPRESSION;
GENE FREQUENCY;
GENE MUTATION;
GENETIC POLYMORPHISM;
GENETIC STABILITY;
GENOTYPE;
HETEROZYGOSITY;
HETEROZYGOTE;
HUMAN;
MAJOR CLINICAL STUDY;
PHENOTYPE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
ADENOSINE TRIPHOSPHATASES;
ALLELES;
ANIMALS;
BLOOM SYNDROME;
CASE-CONTROL STUDIES;
COLORECTAL NEOPLASMS;
DNA HELICASES;
FEMALE;
GENES, APC;
GENETIC PREDISPOSITION TO DISEASE;
HETEROZYGOTE;
HUMANS;
ISRAEL;
JEWS;
MALE;
MICE;
MUTATION;
NEW YORK;
RISK FACTORS;
|
EID: 18544386262
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1074399 Document Type: Article |
Times cited : (161)
|
References (8)
|